Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph H. Gleiter

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Rejuvenation Research|April 8, 2010
Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer diseaseLusine Danielyan, Roman Klein, Leah R Hanson, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 4, 2003
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]Reinhild Bücheler, Christoph Meisner, Klaus Mörike, et al.
The Lancet. Infectious Diseases|November 21, 2009
Pharmacogenetics of antimalarial drugs: effect on metabolism and transportReinhold Kerb, Richard Fux, Klaus Mörike, et al.
Journal of the American Society for Mass Spectrometry|July 29, 2008
Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysisDino Bullinger, Richard Fux, Graeme Nicholson, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 20, 2008
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patientsAntje Frickenschmidt, Holger Frohlich, Dino Bullinger, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2013
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trialsChristiane Reinert, Lukas Kremmler, Susen Burock, et al.
Journal of Clinical Pharmacology|March 26, 2009
The targeted oral, once-daily phosphodiesterase 4 inhibitor roflumilast and the leukotriene receptor antagonist montelukast do not exhibit significant pharmacokinetic interactionsGabriele M Böhmer, Nassr Nassr, Marcus Wenger, et al.
European Journal of Cell Biology|December 3, 2005
Similar protective effects of BQ-123 and erythropoietin on survival of neural cells and generation of neurons upon hypoxic injuryLusine Danielyan, Lars Mueller, Barbara Proksch, et al.
European Journal of Cell Biology|July 12, 2005
The blockade of endothelin A receptor protects astrocytes against hypoxic injury: common effects of BQ-123 anderythropoietin on the rejuvenation of the astrocyte populationLusine Danielyan, Oleg Gembizki, Barbara Proksch, et al.
The Journal of Investigative Dermatology|September 30, 2006
Colocalization of glial fibrillary acidic protein, metallothionein, and MHC II in human, rat, NOD/SCID, and nude mouse skin keratinocytes and fibroblastsLusine Danielyan, Genrich Tolstonog, Peter Traub, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Rejuvenation Research|April 8, 2010
Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer diseaseLusine Danielyan, Roman Klein, Leah R Hanson, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 4, 2003
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]Reinhild Bücheler, Christoph Meisner, Klaus Mörike, et al.
The Lancet. Infectious Diseases|November 21, 2009
Pharmacogenetics of antimalarial drugs: effect on metabolism and transportReinhold Kerb, Richard Fux, Klaus Mörike, et al.
Journal of the American Society for Mass Spectrometry|July 29, 2008
Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysisDino Bullinger, Richard Fux, Graeme Nicholson, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 20, 2008
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patientsAntje Frickenschmidt, Holger Frohlich, Dino Bullinger, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2013
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trialsChristiane Reinert, Lukas Kremmler, Susen Burock, et al.
Journal of Clinical Pharmacology|March 26, 2009
The targeted oral, once-daily phosphodiesterase 4 inhibitor roflumilast and the leukotriene receptor antagonist montelukast do not exhibit significant pharmacokinetic interactionsGabriele M Böhmer, Nassr Nassr, Marcus Wenger, et al.
European Journal of Cell Biology|December 3, 2005
Similar protective effects of BQ-123 and erythropoietin on survival of neural cells and generation of neurons upon hypoxic injuryLusine Danielyan, Lars Mueller, Barbara Proksch, et al.
European Journal of Cell Biology|July 12, 2005
The blockade of endothelin A receptor protects astrocytes against hypoxic injury: common effects of BQ-123 anderythropoietin on the rejuvenation of the astrocyte populationLusine Danielyan, Oleg Gembizki, Barbara Proksch, et al.
The Journal of Investigative Dermatology|September 30, 2006
Colocalization of glial fibrillary acidic protein, metallothionein, and MHC II in human, rat, NOD/SCID, and nude mouse skin keratinocytes and fibroblastsLusine Danielyan, Genrich Tolstonog, Peter Traub, et al.
Pageof 7